Author

K. Hezaveh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. P. McGuigan· 1 shared C. A. Simmons· 1 shared C. H. Arrowsmith· 1 shared E. D'Arcangelo· 1 shared F. Sun· 1 shared H. Liu· 1 shared J. Muffat· 1 shared L. Ailles· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. P. McGuigan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EHMT2/G9a-Inhibition Reprograms Cancer-Associated Fibroblasts (CAFs) to a More Differentiated, Less Proliferative and Invasive State

N. C. Wu, R. Quevedo, M. Nurse, K. Hezaveh, H. Liu, F. Sun, J. Muffat, Y. Sun, C. A. Simmons, T. L. McGaha, P. Prinos, C. H. Arrowsmith, L. Ailles, E. D'Arcangelo, A. P. McGuigan

This study identifies EHMT2 as a key regulator of CAF hyperproliferation and pro-invasive behavior, showing its inhibition reprograms CAFs to a less aggressive state.

bioRxiv · Jul 17, 2023 · PreprintCancer Biology